144
96.
Amaral A., Opal S.M., Vincent J.L. Coagulation in sepsis // Intensive
Care Med., 2004,v. 30., p. 1032-1040.
97.
Amiral J., Walenga J. M., Fareed J. Development and performance
characteristics of a competitive enzyme immunoassay for fibrinopeptide A // Semin.
Thrombos. Hemostasis., 2004, v. 10., p. 228-242.
98.
Amiral J., Fareed J. Thromboembolic diseases: biochemical mechanisms
and new possibilities of biological diagnosis // Semin Thromb Hemost., 1996, v. 22.
p. 41-48.
99.
Angstwurm M.W., Reininger A.J., Spannagl M. D-dimer as marker for
microcirculatory failure: correlation with LOD and APACHE II scores // Tromb.
Res., 2004, v. 113, p. 353-359.
100.
Auger M. J., Galloway M. J., Leinster S. L., McVerry B.A et al.
Elevated fibrinopeptide A levels in patients with clinically localized breast
carcinoma // Haemostasis., 1997, v. 17., p. 336-339.
101.
Asakura H., Wada H., Okamoto K. et al. Evaluation of haemostatic
molecular markers for diagnosis of disseminated intravascular coagulation in patients
with infections // Thromb. Haemost., 2006, v. 95.,p. 282-287.
102.
Auriant I., Vinatier I., Thaler F. et al. Simplified acute physiology score
II for measuring severity of illness in intermediate care units // Crit. Care Med.,
1998,v.26., p. 1368-1371.
103.
Baue A.E., Durham R., Faist E. Systemic inflammatory response
(SIRS), multiple organ dysfunction syndrom (MODS), multiple organ failure (MOF):
are we winning the battle // Shock., 1998,v. 10, p. 79-89.
104.
Bauer K.A. Activation marker of coagulation // Best Prak. Res. Clin.
Haematol., 1999, v. 12, p. 387-406.
105.
Bellart J., Gilabert R., Angles A., Piera V., Miralles R.M, et al. Tissue
factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial
procoagulant disorder in pre-eclampsia // Br. J. Obstet. Gynaecol, 1999, v. 106, p.
594-597.
145
106.
Bernard
G.R.
Quantification
of
organ
dysfunction:
seeking
standardization // Crit. Care med., 1998,v. 26, p. 1767-1768.
107.
Bernard G.R., Fly E.W., Wright T.J. et al., Safety and dose relationship
of recombinant human activated protein C for coagulopathy in severe sepsis // Crit.
Care Med., 2001, v. 29, p. 2051-2059.
108.
Bick R.L. Disseminated intravascular coagulation: objective clinical and
laboratory diagnosis, treatment and assessment of therapeutic response // Semin.
Thromb. Haemost., 1996, v. 22, p. 69-88.
109.
Bick R.L., Arun B., Frenkel E.P. Disseminated intravascular
coagulation. Clinical and pathophysiological mechanisms and manifestations //
Haemostasis., 1999, v. 29, p. 111-134.
110.
Bick R.L. Disseminated intravascular coagulation. Current concepts of
etiology, pathophysiology, diagnosis, and treatment // Hematol. Oncol. Clin. N.Am.,
2003, v.17, p. 149-176.
111.
Bone R.C. Toward an epidemiology and history of SIRS (systemic
inflammatory response syndrome) // JAMA, 1992, v. 268, p. 3452-3455.
112.
Bone R.C. Immunologic dissonance: a continuing evolution in our
understanding off the systemic inflammatory response syndrome (SIRS) and the
multiple organ dysfunction syndrome (MODS) // Ann. Inter. Med, 1996, v. 125, p.
680-687.
113.
Bounameaux H., Cirafici P., Moerloose P.D. et al. Measurement of D-
dimer in plasma as diagnostic aid in suspected pulmonary embolism // Lancet, 1991,
v. 337, p. 196-200.
114.
Bradley EL 3rd. (1993). «A clinically based classification system for
acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis,
Atlanta, GA, September 11 through 13, 1992.». Arch Surg 128: pp. 586–590.
115.
Brenner B., Francis C.W., Fitzpatrick P.G. et al. Relation of plasma D -
dimer concentrations to coronary artery reperfusion before and after thrombolytic
treatment in patients with acute myocardial infarction // AM. J. Cardiol, 1989, v.
63, p. 1179-1184.
146
116.
Burdon D., Tiedje T., Pfeffer K. et al. The role of tumor necrosis factor
in the development of multiple organ failure in a murine model // Crit. Care Med.,
2000, v. 28, p. 1962-1967.
117.
Caccese D., Pratico D., Ghiselli A. et al. Superoxide anion and hydroxyl
radical release by collagen-induced platelet aggregation role of arachidonic acid
metabolism // Thromb. Haemost., 2000, v. 83, p. 485-490.
118.
Cameron J. L. Current Surgical Therapy. 9
th
edition. Philadelphia 2008.
119.
Carey
M.J.,
Rogers
G.M.
Disseminated
intravascular
coagulationrclinical and laboratory aspects // Am. J. Hematol., 1998, v. 59, p. 65-73.
120.
Carr J.M., McKinney M., McDonagh J. Diagnosis of disseminated
intravascular coagulation // Am. J. Clin. Pathol., 1989, v. 91, p. 280-287.
121.
Catani M.V., Bernassola F., Rossi A., Melino G. Inhibition of clotting
factor XIII activity by nitric oxide // Biochem. Biophys. Resear. Com., 1998, v. 249,
p. 275-278.
122.
ChenT. Y., Huang C. C., Tsao C. J.Constant, Domin- Regulated
Antibody Catalysis // Am. J. Hematol, 1993, v. 44, p. 276-279.
123.
Cominotti S., Summa P., Maraggia D. et al. Septic pancreatic necrosis
in intensive care // Minerva Anestesiol., 1999, v. 65, p. 799-805.
124.
Cook D.J., Crowther M.A., Douketis J. et al. Research agenda: venous
thromboembolism in medical-surgical critically ill patients // J. Crit. Care., 2005, v.
20, p. 330-333.
125.
Coppola A., Davi G., De Stefano V. et al. Homocysteine, coagulation,
platelet function, and thrombosis // Semin. Thromb. Hemost., 2000, v.26, p. 243-254.
126.
Cuschieri A., Steel R. J., Moosa A. R. Disorders of stomach and
duodenum // Essential surgical practice. 4-th ed. London: Arnold; 2002.p.261-319
127.
Cuschieri S. A., Steel R. J., Moosa A.R.Patients with postoperative
complications // Basic surgical training. 4-th ed. 2002., p 422-423
128.
Damas P., Canivet J.L., Groote D.D. Sepsis and serum cytokine
concentrations// Crit. Care Med., 1997, v. 25, p. 405-412.
Dostları ilə paylaş: |